Amgen Says Bone Drug Cut Fractures in Big Trial - Wall Street Journal
 Ontario Now | Amgen Says Bone Drug Cut Fractures in Big Trial Wall Street Journal - By MARILYN CHASE In a summary of results from a big clinical trial, Amgen Inc. said its experimental bone drug shored up skeletal strength and reduced spinal fractures in men undergoing hormone-blocking treatment for prostate cancer. Amgen’s Bone Drug Meets Endpoint In Phase III Trial UPDATE 1-Drug prevents bone loss in prostate cancer - Amgen |